Bone Biologics announces secondary stock offering; shares down

Bone Biologics

13/06/2023 15:37

** Medical device company Bone Biologics Corp  BBLG.O  down
10.9% at $4.39 in early trading 
    ** Secondary sale of 1.11 mln shares for gross proceeds of
$5.4 mln; also offering warrants
    ** Offering price of $5.40/share 8.7% higher than last close
    ** Co says it intends to use net proceeds to fund planned
clinical trials and retain contract research organization
partners
    ** YTD, shares of Bone Biologics down 29.82% including
session moves

 (Reporting by Pritam Biswas)
 ((Pritam.Biswas@thomsonreuters.com))